Critical Care

official impact factor 4.60

Open Access Highly Access

Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates

Heleen M Oudemans-van Straaten*, Muriel van Schilfgaarde, Pascal J Molenaar, Jos PJ Wester and Anja Leyte

Critical Care 2009, 13:R193 doi:10.1186/cc8191

Accesses  

  • Last 30 days: 62 accesses
  • Last 365 days: 767 accesses
  • All time: 3343 accesses

Cited by

BioMed Central: 1 citation

Review   Free

Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?

Heleen M Oudemans-van Straaten, John A Kellum, Rinaldo Bellomo Critical Care 2010, 15:202 (24 January 2011)